Austar Lifesciences Anticipates Profit Turnaround

Austar Lifesciences Ltd. (HK:6118) has released an update.

Austar Lifesciences Ltd. has issued a positive profit alert, expecting a profit of RMB 3-6 million for the first half of 2024, a significant improvement over the RMB 40 million loss in the same period of 2023. The anticipated profit is credited to the absence of losses from certain subsidiaries and a reduction in operating expenses due to organizational optimization. Investors are advised to exercise caution when dealing in the company’s shares until the interim results are officially published in late August 2024.

For further insights into HK:6118 stock, check out TipRanks’ Stock Analysis page.